RESUMEN
Vulvovaginitis is a common gynecologic complaint in prepubertal girls. It typically presents with complaints of vulvovaginal itching, burning, irritation, discharge, or skin changes. Prepubertal females have anatomic, physiological, and behavioral factors that most often contribute to the development of symptoms. Careful attention to history and associated complaints will direct evaluation, diagnosis, and treatment. Most cases are nonspecific in origin and treatment includes counseling to patients and parents on hygiene and voiding techniques. Antibiotic treatment for specific pathogens may be indicated. Other less common causes include foreign bodies and lichen sclerosus.
Asunto(s)
Antibacterianos/administración & dosificación , Examen Ginecologíco/métodos , Higiene/educación , Educación del Paciente como Asunto/métodos , Desarrollo Sexual/fisiología , Vulvovaginitis , Niño , Femenino , Productos para la Higiene Femenina , Humanos , Factores de Riesgo , Micción/fisiología , Vulvovaginitis/metabolismo , Vulvovaginitis/microbiología , Vulvovaginitis/fisiopatología , Vulvovaginitis/terapiaRESUMEN
Recurrent vulvovaginal infections (RVVI), a devastating group of mucosal infection, are severely affecting women's quality of life. Our understanding of the vaginal defense mechanisms have broadened recently with studies uncovering the inflammatory nature of bacterial vaginosis, inflammatory responses against novel virulence factors, innate Type 17 cells/IL-17 axis, neutrophils mediated killing of pathogens by a novel mechanism, and oxidative stress during vaginal infections. However, the pathogens have fine mechanisms to subvert or manipulate the host immune responses, hijack them and use them for their own advantage. The odds of hijacking increases, due to impaired immune responses, the net magnitude of which is the result of numerous genetic variations, present in multiple host genes, detailed in this review. Thus, by underlining the role of the host immune responses in disease etiology, modern research has clarified a major hypothesis shift in the pathophilosophy of RVVI. This knowledge can further be used to develop efficient immune-based diagnosis and treatment strategies for this enigmatic disease conditions. As for instance, plasma-derived MBL replacement, adoptive T-cell, and antibody-based therapies have been reported to be safe and efficacious in infectious diseases. Therefore, these emerging immune-therapies could possibly be the future therapeutic options for RVVI.
Asunto(s)
Susceptibilidad a Enfermedades/inmunología , Interacciones Huésped-Patógeno/inmunología , Vulvovaginitis/etiología , Inmunidad Adaptativa , Femenino , Predisposición Genética a la Enfermedad , Interacciones Huésped-Patógeno/genética , Humanos , Inmunidad Innata , Estrés Oxidativo , Polimorfismo de Nucleótido Simple , Receptores de Reconocimiento de Patrones/metabolismo , Recurrencia , Vagina/inmunología , Vagina/metabolismo , Vagina/microbiología , Vagina/patología , Vulvovaginitis/diagnóstico , Vulvovaginitis/epidemiología , Vulvovaginitis/metabolismoRESUMEN
OBJECTIVES: Exploratory pilot study to determine the correlation between postmenopausal vulvovaginal symptoms and vaginal cytokine levels. METHODS: Postmenopausal women (n = 34) not using menopausal hormone therapy and presenting with or without symptoms of vulvovaginal irritation were screened. Each participant underwent a vaginal examination and screening for vaginitis. A cervicovaginal lavage (CVL) with sterile saline and a peripheral blood sample were obtained. Main outcome measures were assessed by Luminex® X-map method on the Bio-Plex® platform. Main outcome measures were cervicovaginal and serum interleukin (IL)-4, IL-5, IL-10, IL-12, IL-13, TNF-α, GM-CSF, MIP-1-alpha and RANTES level. Cervicovaginal cytokines were adjusted to total protein concentration [pg/mcg protein]. RESULTS: Twenty-six postmenopausal women were enrolled (symptomatic: n = 15; asymptomatic: n = 11). There were no significant differences between groups: age, age at menopause, vaginal pH and all CVL and serum cytokines (IL-4, IL-5, IL-10, IL-12, IL-13, TNF-α, GM-CSF, MIP-1-alpha and RANTES). GM-CSF was the most abundant vaginal cytokine (symptomatic: 146.5 ± 165.6 pg/mcg protein; asymptomatic: 146.0 ± 173.5 pg/mcg protein; p = 0.99). CONCLUSIONS: Postmenopausal vulvovaginal symptoms did not correlate with vaginal inflammatory marker. There was no difference in serum or CVL cytokines between symptomatic and asymptomatic postmenopasual women. Vaginal symptoms after menopause are not related to the vaginal cytokine changes associated with loss of estrogen.
Asunto(s)
Envejecimiento , Citocinas/metabolismo , Membrana Mucosa/metabolismo , Vagina/metabolismo , Vulvovaginitis/metabolismo , Atrofia , Biomarcadores/sangre , Biomarcadores/metabolismo , Estudios Transversales , Citocinas/sangre , Femenino , Humanos , Persona de Mediana Edad , Membrana Mucosa/inmunología , Membrana Mucosa/patología , Proyectos Piloto , Posmenopausia , Índice de Severidad de la Enfermedad , Vagina/inmunología , Vagina/patología , Ducha Vaginal , Vulvovaginitis/inmunología , Vulvovaginitis/patología , Vulvovaginitis/fisiopatologíaRESUMEN
PURPOSE: To establish a correlation between pH vaginal and the microflora associated in carriers of vulvovaginites. METHODS: In the present study, the cytopathological examination and the vaginal flow in a group of 65 sexually active women had been carried through, 20 and 72 years, taken care of in the Laboratório de Citologia Clínica do Departamento de Análises Clínicas e Toxicológicas da Universidade Federal do Rio Grande do Norte, for determination of microorganisms in cervicovaginal sample and of pH in the vaginal flow. RESULTS: Associating pH vaginal with the presence of vulvovaginitis, it was evidenced that the Candida sp. occurred more frequently in pH 4.0, Trichomonas vaginalis in pH 6.0, Gardnerella vaginalis in pH 5.0, coconuts in pH 5.0, bacilli in pH 4.0 and cocos/bacilos in pH 6.0. It was observed that all the patients had presented at least one type of ethiological agent of vulvovaginiti and an associated microflora. CONCLUSION: The joint accomplishment of the cytological examinations and the determination of pH revealed important for directing the microflora associated with the vulvovaginiti, suggesting, of this form, that pH vaginal plays preponderant role how much to the presence of the infectious agents in the vaginal ecosystem.
Asunto(s)
Vagina/microbiología , Frotis Vaginal , Vulvovaginitis , Adulto , Anciano , Animales , Candida/aislamiento & purificación , Candidiasis Vulvovaginal/complicaciones , Femenino , Gardnerella vaginalis/aislamiento & purificación , Humanos , Concentración de Iones de Hidrógeno , Persona de Mediana Edad , Vaginitis por Trichomonas/complicaciones , Trichomonas vaginalis/aislamiento & purificación , Vagina/química , Vaginosis Bacteriana/complicaciones , Vulvovaginitis/metabolismo , Vulvovaginitis/microbiologíaRESUMEN
PURPOSE: To establish a correlation between pH vaginal and the microflora associated in carriers of vulvovaginites. METHODS: In the present study, the cytopathological examination and the vaginal flow in a group of 65 sexually active women had been carried through, 20 and 72 years, taken care of in the Laboratório de Citologia Clínica do Departamento de Análises Clínicas e Toxicológicas da Universidade Federal do Rio Grande do Norte, for determination of microorganisms in cervicovaginal sample and of pH in the vaginal flow. RESULTS: Associating pH vaginal with the presence of vulvovaginitis, it was evidenced that the Candida sp. occurred more frequently in pH 4.0, Trichomonas vaginalis in pH 6.0, Gardnerella vaginalis in pH 5.0, coconuts in pH 5.0, bacilli in pH 4.0 and cocos/bacilos in pH 6.0. It was observed that all the patients had presented at least one type of ethiological agent of vulvovaginiti and an associated microflora. CONCLUSION: The joint accomplishment of the cytological examinations and the determination of pH revealed important for directing the microflora associated with the vulvovaginiti, suggesting, of this form, that pH vaginal plays preponderant role how much to the presence of the infectious agents in the vaginal ecosystem.
Asunto(s)
Adulto , Anciano , Animales , Femenino , Humanos , Persona de Mediana Edad , Frotis Vaginal , Vulvovaginitis , Vagina/microbiología , Candida/aislamiento & purificación , Candidiasis Vulvovaginal/complicaciones , Gardnerella vaginalis/aislamiento & purificación , Concentración de Iones de Hidrógeno , Trichomonas vaginalis/aislamiento & purificación , Vagina/química , Vaginitis por Trichomonas/complicaciones , Vaginosis Bacteriana/complicaciones , Vulvovaginitis/metabolismo , Vulvovaginitis/microbiologíaRESUMEN
The expression of the 60-kD and 70-kD heat shock proteins (hsp60 and hsp70) in the vaginas of 43 asymptomatic women of reproductive age with or without a history of recurrent vulvovaginitis (RVV) were compared. Vaginal wash samples were obtained and assayed by enzyme-linked immunosorbent assay (ELISA) for human hsp60 and hsp70. Heat shock protein 70 was not detected in any of the 19 women with no history of RVV, and hsp60 was present in only one woman in this group. In contrast, in the RVV group, 11 (45.8%) were hsp60-positive and eight (33.3%) were hsp70-positive. The presence of either heat shock protein in the vagina was associated with an elevated vaginal pH (>4.5). Bacterial vaginosis or Candida was identified in some of the asymptomatic subjects; their occurrence was significantly higher in women with vaginal hsp70 than in women with no heat shock proteins. Oral contraceptives were used by 35.7% of subjects who were negative for vaginal heat shock proteins, as opposed to only 12.5% of women who were positive for hsp70 and 8.3% who were positive for hsp60. Expression of heat shock proteins in the vagina may indicate an altered vaginal environment and a susceptibility to vulvovaginal symptoms.
Asunto(s)
Chaperonina 60/metabolismo , Proteínas HSP70 de Choque Térmico/metabolismo , Vagina/metabolismo , Vulvovaginitis/metabolismo , Adulto , Anticoncepción/métodos , Femenino , Humanos , Concentración de Iones de Hidrógeno , Recurrencia , Vagina/microbiología , Vulvovaginitis/microbiologíaRESUMEN
OBJECTIVES: The cause of recurrent vulvovaginitis remains unexplained in most cases. Heat shock protein synthesis is induced under conditions of stress; its presence in vaginal samples from women who were between episodes of recurrent vulvovaginitis thus might reflect a persistent perturbation in the local milieu. STUDY DESIGN: We undertook an evaluation by means of enzyme-linked immunosorbent assay of 60-kd heat shock protein and inducible 70-kd heat shock protein expressions in vaginal wash samples from 24 symptom-free women with a history of recurrent vulvovaginitis and 19 matched control subjects. The samples were also tested for Candida albicans, Chlamydia trachomatis, Ureaplasma urealyticum, Mycoplasma hominis, and human papillomavirus by polymerase chain reaction; for bacterial vaginosis by clinical and microbiologic evaluation; and for interleukin 10, interleukin 1, interleukin 8, RANTES, and eotaxin by enzyme-linked immunosorbent assay. RESULTS: The presence of 60-kd heat shock protein was detected in 11 women with recurrent vulvovaginitis (45.8%) and 1 control subject (5.3%, P =.005). Similarly, 70-kd heat shock protein was present in 8 patients with recurrent vulvovaginitis (33.3%) and no control subjects (P =.005). The presence of 60-kd heat shock protein and the presence of 70-kd heat shock protein were correlated with each other (P =.02), as were both 60-kd heat shock protein (P =.006) and 70-kd heat shock protein (P =.01) correlated with IL-10. There was no relation between the presence of 60-kd heat shock protein or 70-kd heat shock protein and detection of IL-1, IL-8, or any microorganism. CONCLUSION: The expression of heat shock proteins and IL-10 in the vaginas of women with a history of recurrent vulvovaginitis but not in the vaginas of control subjects suggests the existence of differences in the vaginal milieu between the 2 groups, even when both are without vaginal symptoms.
Asunto(s)
Chaperonina 60/metabolismo , Proteínas HSP70 de Choque Térmico/metabolismo , Vulvovaginitis/metabolismo , Adulto , Candida albicans/aislamiento & purificación , Estudios de Casos y Controles , Chlamydia trachomatis/aislamiento & purificación , Femenino , Regulación de la Expresión Génica , Humanos , Interleucinas/metabolismo , Persona de Mediana Edad , Mycoplasma hominis/aislamiento & purificación , Papillomaviridae/aislamiento & purificación , Reacción en Cadena de la Polimerasa , Recurrencia , Ureaplasma urealyticum/aislamiento & purificación , Vagina/inmunología , Vagina/metabolismo , Vagina/microbiología , Vulvovaginitis/microbiología , Vulvovaginitis/virologíaRESUMEN
The pharmacokinetics of metronidazole was studied in 20 paediatric patients aged 6 weeks and 4 to 14 years, who had trichomonal vaginitis or an anaerobic bacterial infection. The dosage of metronidazole was about 10 or 20 mg/kg b.i.d. orally. The serum concentrations found in children and the corresponding calculated kinetic parameters were similar to those in adults after intake of an equal, weight-related dose. Metronidazole shows rapid diffusion into the saliva with a concentration ratio of about 1.0. This can provide the basis for an efficient non-invasive method of drug monitoring.